Funding Opportunities
Funding Opportunities
This page provides information on active and archived Regenerative Medicine Innovation Project (RMIP) funding opportunities.
Title: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required)
ID Number:
Activity Code: / Exploratory/Developmental Phased Award Cooperative Agreement
Earliest Submission Date: September 6, 2022
Application Due Date: October 6, 2022
Title: Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 – Clinical Trial Not Allowed)
ID Number:
Activity Code: Research Project – Cooperative Agreements
Earliest Submission Date: September 6, 2022
Application Due Date: October 6, 2022
Title: Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
ID Number:
Activity Code: Planning Grant
Earliest Submission Date: September 6, 2022
Application Due Date: October 6, 2022
ID Number:
Activity Code: / Exploratory/Developmental Phased Award Cooperative Agreement
Earliest Submission Date: September 8, 2021
Application Due Date: October 8, 2021
Title: RMIP Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required)ID Number:
Activity Code: / Exploratory/Developmental Phased Award Cooperative Agreement
Earliest Submission Date: September 2, 2020
Application Due Date: October 2, 2020
RMIP Investigator-Initiated Clinical Trials
ID Number: RFA-HL-20-030
Activity Code: – Clinical Trial Required
Earliest Submission Date: September 18, 2019
Application Due Date: October 18, 2019
Title:
ID Number: RFA-HL-18-030
Activity Code: – Clinical Trial Not Allowed
Earliest Submission Date: September 19, 2018
Application Due Date: October 19, 2018
Title:
ID Number: RFA-HL-18-031
Activity Code: / – Clinical Trial Required
Earliest Submission Date: September 19, 2018
Application Due Date: October 19, 2018
Title:
ID Number: RFA-HL-18-033
Activity Code: - Clinical Trial Not Allowed
Earliest Submission Date: September 19, 2018
Application Due Date: October 19, 2018
Title:
ID Number: RFA-HL-18-035
Activity Code: - Clinical Trial Not Allowed
Earliest Submission Date: September 19, 2018
Application Due Date: October 19, 2018
Title:
ID Number: RFA-HL-17-023
Activity Codes: /
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-024
Activity Codes: /
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-025
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-026
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-027
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-028
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-029
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-030
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-031
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-032
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-033
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
Title:
ID Number: RFA-HL-17-034
Activity Code:
Earliest Submission Date: May 26, 2017
Application Due Date: June 26, 2017
This page last reviewed on